328 related articles for article (PubMed ID: 20097924)
1. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.
Hosokawa T; Saito T; Asada A; Fukunaga K; Hisanaga S
Mol Cell Proteomics; 2010 Jun; 9(6):1133-43. PubMed ID: 20097924
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of drebrin by cyclin-dependent kinase 5 and its role in neuronal migration.
Tanabe K; Yamazaki H; Inaguma Y; Asada A; Kimura T; Takahashi J; Taoka M; Ohshima T; Furuichi T; Isobe T; Nagata K; Shirao T; Hisanaga S
PLoS One; 2014; 9(3):e92291. PubMed ID: 24637538
[TBL] [Abstract][Full Text] [Related]
3. Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation.
Kamei H; Saito T; Ozawa M; Fujita Y; Asada A; Bibb JA; Saido TC; Sorimachi H; Hisanaga S
J Biol Chem; 2007 Jan; 282(3):1687-94. PubMed ID: 17121855
[TBL] [Abstract][Full Text] [Related]
4. In vivo analysis of the phosphorylation of tau and the tau protein kinases Cdk5-p35 and GSK3β by using Phos-tag SDS-PAGE.
Hisanaga SI; Krishnankutty A; Kimura T
J Proteomics; 2022 Jun; 262():104591. PubMed ID: 35430389
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
[TBL] [Abstract][Full Text] [Related]
6. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
[TBL] [Abstract][Full Text] [Related]
7. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
8. Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35.
Hosokawa T; Saito T; Asada A; Ohshima T; Itakura M; Takahashi M; Fukunaga K; Hisanaga S
J Neurosci Res; 2006 Sep; 84(4):747-54. PubMed ID: 16802322
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Sox6 by cyclin dependent kinase 5 in brain.
Rudrabhatla P; Utreras E; Jaffe H; Kulkarni AB
PLoS One; 2014; 9(3):e89310. PubMed ID: 24662752
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants.
Kimura T; Hosokawa T; Taoka M; Tsutsumi K; Ando K; Ishiguro K; Hosokawa M; Hasegawa M; Hisanaga S
Sci Rep; 2016 Sep; 6():33479. PubMed ID: 27641626
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA.
Takahashi M; Ishida M; Saito T; Ohshima T; Hisanaga S
Biochem Biophys Res Commun; 2014 May; 447(4):678-82. PubMed ID: 24755075
[TBL] [Abstract][Full Text] [Related]
12. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of adult type Sept5 (CDCrel-1) by cyclin-dependent kinase 5 inhibits interaction with syntaxin-1.
Taniguchi M; Taoka M; Itakura M; Asada A; Saito T; Kinoshita M; Takahashi M; Isobe T; Hisanaga S
J Biol Chem; 2007 Mar; 282(11):7869-76. PubMed ID: 17224448
[TBL] [Abstract][Full Text] [Related]
14. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
[TBL] [Abstract][Full Text] [Related]
15. The effect of Cyclin-dependent kinase 5 on voltage-dependent calcium channels in PC12 cells varies according to channel type and cell differentiation state.
Furusawa K; Asada A; Saito T; Hisanaga S
J Neurochem; 2014 Aug; 130(4):498-506. PubMed ID: 24766160
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of AATYK1 by Cdk5 suppresses its tyrosine phosphorylation.
Tsutsumi K; Takano T; Endo R; Fukuda M; Ohshima T; Tomomura M; Hisanaga S
PLoS One; 2010 Apr; 5(4):e10260. PubMed ID: 20422042
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase.
Kesavapany S; Lau KF; Ackerley S; Banner SJ; Shemilt SJ; Cooper JD; Leigh PN; Shaw CE; McLoughlin DM; Miller CC
J Neurosci; 2003 Jun; 23(12):4975-83. PubMed ID: 12832520
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
Asada A; Saito T; Hisanaga S
J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase 5 phosphorylates and induces the degradation of ataxin-2.
Asada A; Yamazaki R; Kino Y; Saito T; Kimura T; Miyake M; Hasegawa M; Nukina N; Hisanaga S
Neurosci Lett; 2014 Mar; 563():112-7. PubMed ID: 24486837
[TBL] [Abstract][Full Text] [Related]
20. Analysis of phosphorylation of the myosin-targeting subunit of myosin light chain phosphatase by Phos-tag SDS-PAGE.
Sutherland C; MacDonald JA; Walsh MP
Am J Physiol Cell Physiol; 2016 Apr; 310(8):C681-91. PubMed ID: 26864694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
